Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech
Best AI Eye Screening Companies
What is AI Eye Screening?
The AI eye screening market is a rapidly growing segment of the healthcare industry that utilizes artificial intelligence technology to detect and diagnose various eye diseases. This market offers a range of solutions, including software platforms and hardware devices, that use machine learning algorithms to analyze images of the eye and identify potential health issues. The benefits of these solutions include increased accuracy and efficiency in detecting eye diseases, which can lead to earlier diagnosis and treatment. Additionally, AI eye screening solutions have the potential to reduce healthcare costs by streamlining the screening process and reducing the need for expensive diagnostic tests. As such, investors may be interested in this market as it presents significant growth opportunities for companies operating in this space.
Expert Collections
Market Map
Similar Markets
Do you compete within AI Eye Screening?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.
Top AI Eye Screening Companies
Digital Diagnostics is an AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The platform includes two autonomous AI systems, IDx-DR and 3DermSpot. The company was founded in 2010 and is based in Coralville, Iowa.
Known Partners
orbis, Western Governors University, Health Choice Network, and 2 more
Key People
Seth Rainford, John Bertrand, Michael Abramoff, and 1 more
All Companies in AI Eye Screening
AEYE Health is an FDA-approved digital health company that aims to enable automated, AI-based diagnostic screening solutions for retinal imaging. AEYE Health was founded in 2018 and is based in New York, New York.
Known Partners
Subscribe, Subscribe
Key People
Subscribe, Subscribe
C. Light operates as a neuro-technology and artificial intelligence (AI) company. The company aims to use artificial intelligence and machine learning techniques to assess changes in eye movement as subtle as one-hundredth the size of a human hair with the help of a new tracking scanning laser ophthalmoscope device. It was founded in 2014 and is based in Medford, Massachusetts.
Key People
Subscribe
Retina is a cloud-based healthcare software designed to increase access to specialized healthcare at scale. Its software uses artificial intelligence (AI) to diagnose diseases such as diabetic retinopathy from pictures of the retina, enabling doctors to detect several diseases that can be seen in the retina in real-time. The company was founded in 2017 and is based in Santa Monica, California.
Key People
Subscribe, Subscribe, Subscribe
RetinAI supports eye care professionals and patients throughout the medical examination process using artificial intelligence (AI). Its solutions rely on advances in medical image analysis, ophthalmology, and machine learning. The company was founded in 2017 and is based in Bern, Switzerland.
Known Partners
Subscribe, Subscribe
Known Customers
Subscribe, Subscribe
Key People
Subscribe, Subscribe
Zilia is the developer of Zilia Ocular, a fondus camera enabling non-invasive, continuous, quantitative, and accurate measurements of oxygenation in targeted regions of the eye fundus, such as the optic nerve head, the retina, or the macula.
Key People
Subscribe, Subscribe, Subscribe
Our Methodology
The ESP matrix leverages data and analyst insight to identify and rank leading private-market companies in a given technology landscape.
What is AI Eye Screening?
The AI eye screening market is a rapidly growing segment of the healthcare industry that utilizes artificial intelligence technology to detect and diagnose various eye diseases. This market offers a range of solutions, including software platforms and hardware devices, that use machine learning algorithms to analyze images of the eye and identify potential health issues. The benefits of these solutions include increased accuracy and efficiency in detecting eye diseases, which can lead to earlier diagnosis and treatment. Additionally, AI eye screening solutions have the potential to reduce healthcare costs by streamlining the screening process and reducing the need for expensive diagnostic tests. As such, investors may be interested in this market as it presents significant growth opportunities for companies operating in this space.
Expert Collections
Market Map
Similar Markets
Do you compete within AI Eye Screening?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.